In a co-branded Scientific American-World Economic Forum session at the Annual Meeting of New Champions, or “Summer Davos,” in Tianjin, China, Editor in Chief Mariette DiChristina leads a discussion with Aura Biosciences CEO Elisabeth de los Pinos Pont, Illumina Executive Chairman Jay Flatley and BGI President Wang Jian on how business and government can bridge the gap between availability and access as genomic technologies move from lab to clinic.